PROCEPT BioRobotics Statistics
Total Valuation
PRCT has a market cap or net worth of $2.06 billion. The enterprise value is $1.83 billion.
Important Dates
The next confirmed earnings date is Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PRCT has 55.64 million shares outstanding. The number of shares has increased by 7.26% in one year.
| Current Share Class | 55.64M |
| Shares Outstanding | 55.64M |
| Shares Change (YoY) | +7.26% |
| Shares Change (QoQ) | +0.96% |
| Owned by Insiders (%) | 2.27% |
| Owned by Institutions (%) | 99.43% |
| Float | 53.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.26 |
| Forward PS | 5.37 |
| PB Ratio | 5.32 |
| P/TBV Ratio | 5.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.21, with a Debt / Equity ratio of 0.21.
| Current Ratio | 9.21 |
| Quick Ratio | 7.71 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -23.64 |
Financial Efficiency
Return on equity (ROE) is -26.40% and return on invested capital (ROIC) is -14.34%.
| Return on Equity (ROE) | -26.40% |
| Return on Assets (ROA) | -12.93% |
| Return on Invested Capital (ROIC) | -14.34% |
| Return on Capital Employed (ROCE) | -19.81% |
| Revenue Per Employee | $363,690 |
| Profits Per Employee | -$111,304 |
| Employee Count | 756 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.27% in the last 52 weeks. The beta is 0.99, so PRCT's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | -46.27% |
| 50-Day Moving Average | 37.06 |
| 200-Day Moving Average | 53.50 |
| Relative Strength Index (RSI) | 56.08 |
| Average Volume (20 Days) | 1,162,075 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PRCT had revenue of $274.95 million and -$84.15 million in losses. Loss per share was -$1.56.
| Revenue | 274.95M |
| Gross Profit | 176.49M |
| Operating Income | -91.76M |
| Pretax Income | -84.15M |
| Net Income | -84.15M |
| EBITDA | -85.92M |
| EBIT | -91.76M |
| Loss Per Share | -$1.56 |
Full Income StatementBalance Sheet
The company has $302.72 million in cash and $79.37 million in debt, giving a net cash position of $223.35 million or $4.01 per share.
| Cash & Cash Equivalents | 302.72M |
| Total Debt | 79.37M |
| Net Cash | 223.35M |
| Net Cash Per Share | $4.01 |
| Equity (Book Value) | 385.80M |
| Book Value Per Share | 6.94 |
| Working Capital | 408.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$83.21 million and capital expenditures -$6.06 million, giving a free cash flow of -$89.27 million.
| Operating Cash Flow | -83.21M |
| Capital Expenditures | -6.06M |
| Free Cash Flow | -89.27M |
| FCF Per Share | -$1.60 |
Full Cash Flow StatementMargins
Gross margin is 64.19%, with operating and profit margins of -33.37% and -30.60%.
| Gross Margin | 64.19% |
| Operating Margin | -33.37% |
| Pretax Margin | -30.60% |
| Profit Margin | -30.60% |
| EBITDA Margin | -31.25% |
| EBIT Margin | -33.37% |
| FCF Margin | n/a |
Dividends & Yields
PRCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.26% |
| Shareholder Yield | -7.26% |
| Earnings Yield | -4.09% |
| FCF Yield | -4.34% |
Dividend DetailsAnalyst Forecast
The average price target for PRCT is $67.14, which is 81.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $67.14 |
| Price Target Difference | 81.71% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 25.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRCT has an Altman Z-Score of 17.09 and a Piotroski F-Score of 4.
| Altman Z-Score | 17.09 |
| Piotroski F-Score | 4 |
